Infliximab and Ulcerative Colitis

Ulcerative colitis (UC) is one of the main forms of inflammatory bowel disease. The condition causes the colon and rectum to become inflamed and ulcerated.

Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD - Mayo Clinic

PDF) Review and clinical perspectives for the use of infliximab in ulcerative colitis

Infliximab concentrations in two non-switching cohorts of patients with inflammatory bowel disease: originator vs. biosimilar

Ulcerative colitis Nature Reviews Disease Primers

PDF) Review Article: Acute Severe Ulcerative Colitis, An Update on Optimal Medical Management

Cureus, Cerebral Venous Sinus Thrombosis is a Reversible Complication of Ulcerative Colitis

Ulcerative colitis - The Lancet

Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis

PDF) Racial Disparities in Infliximab Efficacy for Ulcerative Colitis: Evidence Synthesis and Effect Modification Assessment

Infliximab - Wikipedia

REMICADE® (infliximab) for Moderately to Severely Active Adult UC

Alimentary Pharmacology & Therapeutics, Pharmacology Journal

Ulcerative colitis

Crohn's and Ulcerative Colitis

How ulcerative colitis affects the whole body

What is ulcerative colitis? Ulcerative Colitis Drug Cure Development Project -Kyoto University Gastroenterology

Elucidation of pathogenesis of ulcerative colitis and Crohn's disease: Leading to new treatment methods for refractory inflammatory bowel diseases -- Kindai University